openPR Logo
Press release

Acne Therapeutics Market Size & Growth Analysis Report, 2020-2026

04-23-2021 09:45 AM CET | Health & Medicine

Press release from: Orion Market Research

Acne Therapeutics Market Size & Growth Analysis Report,

The global acne therapeutics market is projected to grow significantly during the forecast period. The market is segmented on the basis of treatment and route of administration. Based on the treatment, the acne therapeutics market is further segmented into medications and other treatments. The medication includes retinoids, antibiotics, hormonal drugs, anti-inflammatory drugs, and others. Based on the route of administration, the market is segmented into oral, topical, and parenteral.

The topical route of administration is primarily used for patients with non-inflammatory or mild inflammatory acne. It includes comedolytic agents such as tretinoin, benzoyl peroxide, antibiotics, and various anti-inflammatory drugs. The topical route of administration includes topical retinoids, topical antimicrobials, and topical antibiotics, among others. Topical retinoids include vitamin A derivatives, which are mainly used in patients with non-inflammatory acne, in combination with other topical and systemic drugs. Topical retinoids are also used as an alternative treatment when oral treatment is stopped. The retinoid used in the topical management of acne includes tretinoin, isotretinoin, adapalene, tazarotene, and retinaldehyde.

To Request a Sample of our Report on Acne Therapeutics Market: https://www.omrglobal.com/request-sample/acne-therapeutics-market

Topical antibiotics are very useful in the treatment of mild to moderate inflammatory acne vulgaris, however, no role in treating the comedonal phase of the disease. Erythromycin and clindamycin are the most commonly used topical antibiotics in acne treatment, both of which are available in different formulations. Antibiotics are not intended to be a monotherapy for acne. For instance, topical antibiotics should only be used in combination with benzoyl peroxide(BPO) to prevent the development of antibiotic-resistant bacteria.

BPO is an organic peroxide derived from a by-product of coal tar, which has become the most widely used topical acne medication in dermatology. BPO treatment alone improves inflammatory acne, and its mechanisms of action include antimicrobial, anti-inflammatory, and keratolytic effects and wound-healing activity. Fixed-dose combination gels of topical antibiotics with BPO are also available, as well as a combined gel formulation of clindamycin with tretinoin aids in treating acne.

Other topical agents including salicylic acid is a topical medication present in many over-the-counter products, which has comedolytic effects,however,it may be less effective than retinoids. Another topical agent, azelaic acid, has antibacterial, comedolytic and anti-inflammatory properties and is considered as a potential first-line monotherapy for female adult patients with acne, and a good choice for maintenancetherapy owing to its good tolerability and safety

Further, numerous players are operatingin the global acne therapeutics market that creates scope for market growth. Players such as Aclaris Therapeutics Inc., Allergan PlcEli Lilly and Co., F. Hoffmann-La Roche AG, LEO Pharma A/S, GlaxoSmithKline Plc, Mylan NV, Novartis AG, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Alma Lasers Ltd., Cynosure Inc., Suneva Medical Inc., and others are significantly contributing to the global acne therapeutics industry growth by adopting various growth strategies.

(Get 15% Discount on Buying this Report)
A full Report of Acne Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/acne-therapeutics-market

Global Acne Therapeutics Market – Segmentation

By Type
Medication
• Retinoids
• Antibiotics
• Hormonal Drugs
• Anti-inflammatory Drugs
• Others
• Other Treatment
By Route of Administration
• Oral
• Topical
• Parenteral

Regional Analysis

North America

• United States
• Canada

Europe
• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific
• India
• China
• Japan
• Rest oF APAC

Rest of The World
• Latin America
• Middle East and Africa

Company Profiles

• Aclaris Therapeutics Inc.
• Allergan Plc
• Alma Lasers Ltd.
• Amgen Inc.
• Aurobindo Pharma Ltd.
• Bausch Health Companies Inc.
• Cipher Pharmaceuticals Inc.
• Cutera Inc.
• Cynosure, Inc.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Galderma SA
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• LEO Pharma A/S
• Lumenis Ltd.
• Mylan NV
• Novartis International AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Suneva Medical, Inc.
• Syneron Medical Ltd.
• Teva Pharmaceuticals Industries Ltd.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/acne-therapeutics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acne Therapeutics Market Size & Growth Analysis Report, 2020-2026 here

News-ID: 2274373 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant